← Back to Search

Behavioral Intervention

Guiding Good Choices for Adolescent Substance Abuse (GGC4H Trial)

Phase 3
Recruiting
Led By Margaret R Kuklinski, PhD
Research Sponsored by University of Washington
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Be younger than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up 3-year follow-up (cohort 1), 2-year follow-up (cohort 2) assessments
Awards & highlights

GGC4H Trial Summary

This trial will test whether the "Guiding Good Choices" program can help prevent substance abuse, depression, and delinquency among adolescents when implemented on a larger scale in pediatric primary care.

Eligible Conditions
  • Adolescent Substance Abuse

GGC4H Trial Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~3-year follow-up (cohort 1), 2-year follow-up (cohort 2) assessments
This trial's timeline: 3 weeks for screening, Varies for treatment, and 3-year follow-up (cohort 1), 2-year follow-up (cohort 2) assessments for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
Incidence of adolescent substance use initiation (alcohol, cigarettes, e-cigarettes, and/or marijuana) through last follow-up
Secondary outcome measures
Incidence of antisocial behavior among adolescents through final follow-up
Mean adolescent anxiety symptom score at final follow-up
Mean adolescent depression symptom score at final follow-up
+3 more
Other outcome measures
Prevalence of any psychiatric disorder (depression, anxiety, or conduct disorder) among adolescents through final extraction
Prevalence of emergency department utilization by adolescents through final extraction
Prevalence of inpatient hospitalization utilization by adolescents through final extraction
+3 more

GGC4H Trial Design

2Treatment groups
Experimental Treatment
Active Control
Group I: Guiding Good ChoicesExperimental Treatment1 Intervention
Enrollment in the intervention, Guiding Good Choices, a substance use initiation prevention program, will be recommended by the pediatrician to parents of those adolescents empaneled with an intervention arm pediatrician
Group II: ControlActive Control1 Intervention
Parents of adolescents empaneled with a control arm pediatrician will not be offered Guiding Good Choices

Find a Location

Who is running the clinical trial?

University of WashingtonLead Sponsor
1,743 Previous Clinical Trials
1,844,234 Total Patients Enrolled
Henry Ford Health SystemOTHER
300 Previous Clinical Trials
2,096,246 Total Patients Enrolled
Kaiser PermanenteOTHER
539 Previous Clinical Trials
24,109,776 Total Patients Enrolled

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

How can I join the ranks of this clinical trial?

"This trial is meant for adolescents aged 11 to 12 who have a history of substance abuse. So far, 3636 patients have been accepted into the study."

Answered by AI

Do the requirements for this trial include being over the age of 30?

"Children aged 11 to 12 can participate in this trial, which is one of 78 studies open to patients under 18 years old. There are also 258 studies open to patients over the age of 65."

Answered by AI

How many people are eligible to participate in this experiment?

"That is correct. Based on the information available on clinicaltrials.gov, this trial is currently looking for enrollees. The first posting was on September 30th, 2019 with the most recent update on May 19th, 2022. A total of 3636 individuals are needed for this study at 3 sites."

Answered by AI

What are the risks associated with the Guiding Good Choices program?

"There is some clinical data that supports the efficacy of Guiding Good Choices, and it has received multiple rounds of safety testing, so it is estimated to be a safe intervention."

Answered by AI

Is this research project recruiting new participants?

"Yes, this clinical trial is still looking for patients. The original posting was on September 30th, 2019 with the most recent update on May 19th, 2022."

Answered by AI
Recent research and studies
~651 spots leftby May 2025